Paul L. Hallenbeck

Paul L. Hallenbeck

Fondateur chez
Seneca Therapeutics, Inc.
Commercial Services
Health Technology
Consumer Services

Profil

Paul L.
Hallenbeck
was the founder of Synbody Biotechnology, Inc. as President & Director since 2010.
Dr. Hallenbeck was the founder of Neotropix, Inc. as President & Chief Executive Officer since 2003.
Dr. Hallenbeck is also the founder of Seneca Therapeutics, Inc. Former job at Novartis Corp.
as Member-Research Board.
Former job at Nisco International Ltd. as President.
Education includes undergraduate degree from Siena College, graduate and doctorate degrees from the University of Illinois.

Postes actifs de Paul L. Hallenbeck

SociétésPosteDébut
Fondateur -

Anciens postes connus de Paul L. Hallenbeck

SociétésPosteFin
Fondateur 01/01/2013
Nisco International Ltd.
President -
Corporate Officer/Principal -
Fondateur -
Voir l'expérience en détail de Paul L. Hallenbeck

Formation de Paul L. Hallenbeck

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

3

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Nisco International Ltd.

Commercial Services

  1. Bourse
  2. Insiders
  3. Paul L. Hallenbeck
🔇